88IV - Public company info - Venus Medtech (Hangzhou) Inc.- H share

Input the stock code or the company name

Venus Medtech (Hangzhou) Inc.- H share, 02500.HK - Cash Flow	2019-12	2018-12	2017-12
Net Cash Flow from Operating Activities	-302,164	-151,467	-82,266
Net Cash Flow from Return on Investments & Servicing of Finance	-5,102	-3,094	-1,510
Interest Received	3,876	0	0
Interest Paid	-8,978	-3,094	-1,510
Dividend Received	0	0	0
Dividend Paid	0	0	0
Others	0	0	0
Taxes (Paid) / Refunded	-5,003	0	0
Net Cash Flow from Investing Activities	-30,969	-194,146	-46,993
Additions to Fixed Assets	-15,709	-14,991	-7,526
Disposal of Fixed Assets	3	50	0
Increase in Investments	-6,443	-192,547	-23,474
Decrease in Investments	0	13,100	28
Net Cash Flow with Related Parties	308,900	445,294	145,895
Others	-317,720	-445,052	-161,916
Net Cash Flow before Financing Activities	-343,238	-348,707	-130,769
Net Cash Flow from Financing Activities	2,586,333	456,261	174,478
New Loans	120,000	80,000	30,000
Loans Repayment	-87,691	-62,386	-1,417
Fixed Income/Debt Instruments	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0
Equity Financing	2,523,928	0	0
Net Cash Flow with Related Parties	308,900	445,294	145,895
Others	-278,804	-6,647	0
Increase(Decrease) in Cash & Cash Equivalents	2,243,095	107,554	43,709
Cash & Cash Equivalents at Beginning of Year	164,914	59,015	13,437
Net Cash Flow due to Change in Exchange Rate/Others	5,245	-1,655	1,869
Cash & Cash Equivalents at End of Year	2,413,254	164,914	59,015
Currency	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Venus Medtech (Hangzhou) Inc.- H share , 02500.HK